FY2023 EPS Estimates for Dexterra Group Inc. (TSE:DXT) Raised by Analyst

Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Rating) – Equities research analysts at William Blair issued their Q1 2024 earnings per share estimates for Pyxis Oncology in a note issued to investors on Thursday, May 11th. William Blair analyst A. Hsieh forecasts that the company will earn ($0.56) per share for the quarter. William Blair has […]

Related Keywords

William Blair ,Goldman Sachs Group Inc ,Pyxis Oncology Inc ,Tower Research Capital ,Bleakley Financial Group ,Nasdaq ,Credit Suisse Group ,Pfizer Inc ,York Mellon Corp ,Dimensional Fund Advisors ,Pyxis Oncology ,Get Rating ,Suisse Group ,Sachs Group ,Research Capital ,Fund Advisors ,New York Mellon Corp ,Pyxis Oncology Daily ,Nasdaq Pyxs ,Pyxs ,Medical ,Earnings Estimates ,